liraglutide

FDA Drug Profile — liraglutide, Victoza, Liraglutide, Saxenda

liraglutide is listed in the FDA National Drug Code directory with 18 NDC codes, marketed under brand names including liraglutide, Victoza, Liraglutide. Available dosage forms: injection, solution, injection, powder.

Drug details

Generic Name
liraglutide
Brand Names
liraglutide, Victoza, Liraglutide, Saxenda
Application Number
ANDA217234
Sponsor
Orbicular Pharmaceutical Technologies Private Limited
NDC Codes
18
Dosage Forms
INJECTION, SOLUTION, INJECTION, POWDER
Routes
SUBCUTANEOUS
Active Ingredients
LIRAGLUTIDE

Indications and Usage

1 INDICATIONS AND USAGE Liraglutide Injection is indicated: as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes mellitus. Limitations of Use : Liraglutide Injection contains liraglutide. Coadministration with other liraglutide-containing products is not recommended. Liraglutide Injection is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated: as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes mellitus ( 1 ). Limitations of Use : Coadministration with other liraglutide-containing products is not recommended.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.